Extravasation injuries are common emergencies in clinical practice. If they are not recognized and treated promptly, they can lead to deleterious functional and cosmetic outcomes. There is a vast range of agents involved in these injuries and marked paucity of evidence to support their specific management. Following an extensive literature review, we outline management principles for clinicians involved in the care of patients with extravasation injuries. Key parameters in deciding appropriate management plans include the volume/toxicity of the agent, the necrosis interval of the injury, patient-related factors, as well as the facilities and expertise available in the setting of individual cases of extravasation.
BellinMFJakobsenJATomassinI. Contrast Media Safety Committee of the European Society of Urogenital Radiology. Contrast medium extravasation injury: guidelines for prevention and management. Eur Radiol. 2002, 12: 2807–12.
4.
BensonLSSathyMJPortRB. Forearm compartment syndrome due to automated injection of computed tomography contrast material. J Orthop Trauma. 1996, 10: 433–6.
5.
BertelliGDiniDFornoGB. Hyaluronidase as an antidote to extravasation of Vinca alkaloids: clinical results. J Cancer Res Clin Oncol. 1994, 120: 505–6.
CohanRHLederRABolickD. Extravascular extravasation of radiographic contrast media. Effects of conventional and low-osmolar agents in the rat thigh. Invest Radiol. 1990, 25: 504–10.
8.
CohanRHDunnickNRLederRABakerME. Extravasation of nonionic radiologic contrast media: efficacy of conservative treatment. Radiology. 1990, 176: 65–7.
9.
CohanRHEllisJHGarnerWL. Extravasation of radiographic contrast material: recognition, prevention, and treatment. Radiology. 1996, 200: 593–604.
10.
CohanRHBullardMAEllisJH. Local reactions after injection of iodinated contrast material: detection, management, and outcome. Acad Radiol. 1997, 4: 711–8.
11.
ColemanJJ3rd, WalkerAPDidolkarMS. Treatment of adriamycin-induced skin ulcers: a prospective controlled study. J Surg Oncol. 1983, 22: 129–35.
12.
CoxRF. Managing skin damage induced by doxorubicin hydrochloride and daunorubicin hydrochloride. Am J Hosp Pharm. 1984, 41: 2410–4.
13.
D’AndreaFOnestiMGNicolettiGF. Surgical treatment of ulcers caused by extravasation of cytotoxic drugs. Scand J Plast Reconstr Surg Hand Surg. 2004, 38: 288–92.
14.
DaviesJGaultDBuchdahlR. Preventing the scars of neonatal intensive care. Arch Dis Child Fetal Neonatal Ed. 1994, 70: F50–1.
15.
DionyssiouDChantesAGravvanisADemiriE. The wash-out technique in the management of delayed presentations of extravasation injuries. J Hand Surg Eur Vol. 2011, 36: 66–9.
16.
DorrRTSobleMAlbertsDS. Efficacy of sodium thiosulfate as a local antidote to mechlorethamine skin toxicity in the mouse. Cancer Chemother Pharmacol. 1988, 22: 299–302.
17.
DorrRTSneadKLiddilJD. Skin ulceration potential of paclitaxel in a mouse skin model in vivo. Cancer. 1996, 78: 152–6.
18.
EnerRAMeglatherySBStylerM. Extravasation of systemic hemato-oncological therapies. Ann Oncol. 2004, 15: 858–62.
19.
FallscheerPKammerERoerenTMeuli–SimmenC. Injury to the upper extremity caused by extravasation of contrast medium: a true emergency. Scand J Plast Reconstr Surg Hand Surg. 2007, 41: 26–32.
20.
FederleMPChangPJConferSOzgunB. Frequency and effects of extravasation of ionic and nonionic CT contrast media during rapid bolus injection. Radiology. 1998, 206: 637–40.
GopalakrishnanPNGoelNBanerjeeS. Saline irrigation for the management of skin extravasation injury in neonates. Cochrane Database Syst Rev. 2012, 2: CD008404.
23.
GöthlinJ. The comparative frequency of extravasal injection at phlebography with steeland plastic cannula. Clin Radiol. 1972, 23: 183–4.
24.
HajarizadehHLebredoLBarrieRWolteringEA. Protective effect of doxorubicin in vitamin C or dimethyl sulfoxide against skin ulceration in the pig. Ann Surg Oncol. 1994, 1: 411–4.
25.
HannonMGLeeSK. Extravasation injuries. J Hand Surg Am. 2011, 36: 2060–5.
26.
HasinoffBB. The use of dexrazoxane for the prevention of anthracycline extravasation injury. Expert Opin Investig Drugs. 2008, 17: 217–23.
27.
HecklerFR. Current thoughts on extravasation injuries. Clin Plast Surg. 1989, 16: 557–63.
28.
JacobsJEBirnbaumBALanglotzCP. Contrast media reactions and extravasation: relationship to intravenous injection rates. Radiology. 1998, 209: 411–6.
KaneRCMcGuinnWDJrDagherRJusticeRPazdurR. Dexrazoxane (Totect): FDA review and approval for the treatment of accidental extravasation following intravenous anthracycline chemotherapy. Oncologist. 2008, 13: 445–50.
31.
KhanMSHolmesJD. Reducing the morbidity from extravasation injuries. Ann Plast Surg. 2002, 48: 628–32.
LangsteinHNDumanHSeeligDButlerCEEvansGR. Retrospective study of the management of chemotherapeutic extravasation injury. Ann Plast Surg. 2002, 49: 369–74.
34.
LarsonDL. Treatment of tissue extravasation by antitumor agents. Cancer. 1982, 49: 1796–9.
LaurieSWWilsonKLKernahanDABauerBSVistnesLM. Intravenous extravasation injuries: the effectiveness of hyaluronidase in their treatment. Ann Plast Surg. 1984, 13: 191–4.
37.
LinderRMUptonJOsteenR. Management of extensive doxorubicin hydrochloride extravasation injuries. J Hand Surg Am. 1983, 8: 32–8.
38.
LothTS. Minimal surgical debridement for the treatment of chemotherapeutic agent induced skin extravasations. Cancer Treat Rep. 1986, 70: 401–4.
39.
LothTSEversmannWWJr.Extravasation injuries in the upper extremity. Clin Orthop Relat Res. 1991, 272: 248–54.
40.
LuedkeDWKennedyPSRietschelRL. Histopathogenesis of skin and subcutaneous injury induced by adriamycin. Plast Reconstr Surg. 1979, 63: 463–5.
41.
MadhavanSNorthfeltDW. Lack of vesicant injury following extravasation of liposomal doxorubicin. J Natl Cancer Inst. 1995, 87: 1556–7.
42.
MemoloMDyerRZagoriaRJ. Extravasation injury with nonionic contrast material. Am J Roentgenol. 1993, 160: 203–4.
43.
MouridsenHTLangerSWButerJ. Treatment of anthracycline extravasation with Savene (dexrazoxane): results from two prospective clinical multicentre studies. Ann Oncol. 2007, 18: 546–50.
PitkänenJAsko–SeljavaaraSGröhnPSundellBHeinonenEAppelqvistP. Adriamycin extravasation: surgical treatment and possible prevention of skin and soft tissue injuries. J Surg Oncol. 1983, 23: 259–62.
46.
PondGDDorrRTMcAleeseKA. Skin ulceration from extravasation of low osmolality contrast medium: a complication of automation. Am J Roentgenol. 1992, 158: 915–6.
47.
RaoVKFeldmanPDDibbellDG. Extravasation injury to the hand by intravenous phenytoin. J Neurosurg. 1988, 68: 967–9.
48.
RudolphRLarsonDL. What is the appropriate management of tissue extravasation by antitumor agents?Plast Reconstr Surg. 1985, 75: 397–405.
49.
RudolphRLarsonDL. Etiology and treatment of chemotherapeutic agent extravasation injuries: a review. J Clin Oncol. 1987, 5: 1116–26.
50.
SbitanyHKoltzPFMaysCGirottoJALangsteinHN. CT contrast extravasation in the upper extremity: strategies for management. Int J Surg. 2010, 8: 384–6.
51.
SchaverienMVEvisonDMcCulleySJ. Management of large volume CT contrast medium extravasation injury: technical refinement and literature review. J Plast Reconstr Aesthet Surg. 2008, 61: 562–5; discussion 565.
52.
SchulmeisterB. Recognizing and managing purple glove syndrome. Crit Care Nurse. 2000, 20: 54–61.
ShamseddineAIKhalilAMKibbiAGAbu NasrTASeoudMAEl SaghirNS. Granulocyte macrophage-colony stimulating factor for treatment of chemotherapy extravasation. Eur J Gynaecol Oncol. 1998, 19: 479–81.
57.
ShenaqSMAbbaseEHFriedmanJD. Soft-tissue reconstruction following extravasation of chemotherapeutic agents. Surg Oncol Clin N Am. 1996, 5: 825–45.
58.
SistromCLGaySBPeffleyL. Extravasation of iopamidol and iohexol during contrast-enhanced CT: report of 28 cases. Radiology. 1991, 180: 707–10.
59.
SteiertAHilleUBurkeW. Subcutaneous wash-out procedure (SWOP) for the treatment of chemotherapeutic extravasations. J Plast Reconstr Aesthet Surg. 2011, 64: 240–7.
60.
TelisselisPHeersGPlockBBaierCNeugebauerRFüchtmeierB. [Emergency open surgical treatment of extravasations of cytostatic agents in the upper extremity]. Handchir Mikrochir Plast Chir. 2010, 42: 247–50.
